Please wait

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13D/A 0000921895-25-002596 0001776353 XXXXXXXX LIVE 2 Common Stock, $0.001 par value per share 10/15/2025 false 0001621221 04301G607 ARTELO BIOSCIENCES, INC. 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075 RYAN NEBEL 212-451-2300 OLSHAN FROME WOLOSKY LLP 1325 Avenue of the Americas New York NY 10019 0001776353 N Farb Daniel Stuart PF N Z4 153003.00 0.00 153003.00 0.00 153003.00 N 7.7 IN Common Stock, $0.001 par value per share ARTELO BIOSCIENCES, INC. Item 4 is hereby amended to add the following: On October 15, 2025 (the "Effective Date"), the Reporting Person and certain of his affiliates (collectively, the "Farb Parties") entered into a letter agreement (the "Agreement") with the Issuer. Pursuant to the Agreement, the Reporting Person agreed to irrevocably withdraw his nomination of director candidates for election to the Board at the Issuer's 2025 annual meeting of stockholders. Pursuant to the Agreement, the Farb Parties agreed to certain standstill restrictions and voting commitments during the Restricted Period (as defined in the Agreement), including, among other things, (i) an obligation to vote the Shares beneficially owned by the Farb Parties, and that the Farb Parties have the right to vote, subject to certain limited exceptions, in favor of the election of each person nominated by the Board for election as a director, against any proposals to remove any member of the Board, and in accordance with the recommendation of the Board on all other proposals or business, and (ii) a restriction on the ability of the Farb Parties to acquire an ownership interest of more than 8.0% of the outstanding Shares. The Issuer and the Farb Parties also made certain customary representations, agreed to certain mutual non-disparagement obligations that remain in effect during the Restricted Period, and agreed to a general mutual release of claims with respect to one another for any matter arising on or prior to the Effective Date. The foregoing description of the Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Agreement, which is attached as Exhibit 99.1 hereto and is incorporated herein by reference. Item 6 is hereby amended to add the following: On October 15, 2025, the Farb Parties and the Issuer entered into the Agreement as defined and described in Item 4 above and attached as Exhibit 99.1 hereto. Also on October 15, 2025, the Reporting Person delivered a notice to Scott Pomfret terminating the JFSA in accordance with the terms thereof. Item 7 is hereby amended to add the following exhibit: 99.1 - Agreement, dated October 15, 2025, by and among the Farb Parties and the Issuer. Farb Daniel Stuart /s/ Daniel S. Farb Daniel S. Farb 10/17/2025